Basics |
Company: |
PharmaCyte Biotech, Inc. |
IPO Date: |
December 5, 2003 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$12.26M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.06 | 2.52%
|
Avg Daily Range (30 D): |
$0.04 | 2.57%
|
Avg Daily Range (90 D): |
$0.04 | 2.44%
|
Institutional Daily Volume |
Avg Daily Volume: |
.52M |
Avg Daily Volume (30 D): |
.02M |
Avg Daily Volume (90 D): |
.02M |
Trade Size |
Avg Trade Size (Sh.): |
276 |
Avg Trade Size (Sh.) (30 D): |
313 |
Avg Trade Size (Sh.) (90 D): |
299 |
Institutional Trades |
Total Inst.Trades: |
16 |
Avg Inst. Trade: |
$1.4M |
Avg Inst. Trade (30 D): |
$1.07M |
Avg Inst. Trade (90 D): |
$1.07M |
Avg Inst. Trade Volume: |
.37M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.52M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
209.41K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.39
|
$1.9
|
$-.33
|
Diluted EPS
|
$-.39
|
$1.9
|
$-.33
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -4.43M
|
$ 23.42M
|
$ 1.35M
|
Operating Income / Loss
|
$ -1.11M
|
$ -1.27M
|
$ -3.17M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -11.8M
|
$ -17.54M
|
$ -11.03M
|
PE Ratio
|
|
|
|
Splits |
Jul 12, 2021:
1500:1
|
Dec 08, 2003:
1:3
|
|